Desfechos clínicos e gravidade da infecção pelo Clostridioides (Clostridium) difficile em um hospital terciário de referência no Brasil / Clinical outcome and severity of clostridioides (clostridium) difficile infection at a tertiary referral hospital in brazil

ABSTRACT Background: Clostridioides difficile infection (CDI) is a potentially severe disease that can present with refractoriness, recurrence, and evolution to death. In Brazil, the epidemiology of CDI seems to differ from that of the United States and most European countries, with only one ribotype (RT) 027-related case and a high prevalence of RT106. Objective: The aim of this study was to evaluate the outcomes of CDI and its possible association with ribotypes at a university hospital in Brazil. Methods: A total of 65 patients with CDI were included and stool samples were submitted to A/B toxin detection and toxigenic culture, and toxigenic isolates (n=44) were also PCR ribotyped. Results: Patients' median age was 59 (20-87) years and there were 16 (24.6%) deaths. The median Charlson comorbidity index (CCI) was 4 (0-15) and 16.9% of the patients had CCI ≥8. The ATLAS score and non-improvement of diarrhea were related to higher mortality. A longer length of hospitalization was related to the enteral nutrition and use of multiple antibiotics. The period between CDI diagnosis and hospital discharge was longer in those who received new antibiotics after diagnosis, multiple antibiotics, and required intensive care treatment. Recurrence was associated with CCI >7. Twenty ribotypes were identified and RT106 was the most frequently detected strain (43.2%). No relationship was observed between the ribotypes and outcomes. CDI was present in patients with more comorbidities. Conclusion: Risk factors for higher mortality, longer hospital stay and recurrence were identified. A diversity of ribotypes was observed and C. difficile strains were not related to the outcomes.

RESUMO Contexto: A infecção pelo Clostridioides difficile (ICD) é uma doença potencialmente grave que pode se apresentar com refratariedade, recidiva e evoluir para óbito. No Brasil, a epidemiologia da ICD parece diferir da dos Estados Unidos e da maioria dos países europeus, com apenas um caso relacionado ao ribotipo (RT) 027 e alta prevalência do RT106. Objetivo: Avaliar os desfechos da ICD e sua possível associação com ribotipos em um hospital universitário do Brasil. Métodos: Um total de 65 pacientes com ICD foram incluídos e amostras de fezes foram submetidas à detecção de toxina A/B e cultura toxigênica e as cepas toxigênicas isoladas (n=44) também foram ribotipadas por PCR. Resultados: A idade mediana dos pacientes foi de 59 (20-87) anos e houve 16 (24,6%) óbitos. A mediana do índice de comorbidade de Charlson (ICC) foi de 4 (0-15) e 16,9% dos pacientes apresentaram ICC ≥8. O escore ATLAS e a não melhora da diarreia foram relacionados a maior mortalidade. Maior tempo de internação esteve relacionado à nutrição enteral e ao uso de múltiplos antibióticos. O período entre o diagnóstico de ICD e a alta hospitalar foi maior naqueles que receberam novos antibióticos após o diagnóstico, múltiplos antibióticos e necessitaram de tratamento intensivo. A recorrência foi associada com ICC >7. Vinte ribotipos foram identificados e o RT106 foi a cepa mais frequentemente detectada (43,2%). Não foi observada relação entre os ribotipos e os desfechos. ICD esteve presente em pacientes com mais comorbidades. Conclusão: Foram identificados fatores de risco para maior mortalidade, maior tempo de internação e recorrência. Uma diversidade de ribotipos foi observada e cepas de C. difficile não foram relacionadas aos desfechos.

Eficácia in sílico do florfenicol no tratamento de pododermatite infecciosa por Fusobacterium necrophorum em ovelhas / In sílico efficacy of florfenicol in the treatment of Fusobacterium necrophorum infectious pododermatitis in sheep

Objetivou-se comparar o efeito in silico do florfenicol nas doses de 20 e 30 mg/Kg em ovinos pelas vias intravenosa (IV) e intramuscular (IM), usando a modelagem PK/PD. Realizou-se uma simulação de Monte Carlo com base nos dados de concentração plasmática de um estudo publicado anteriormente. Calculou-se a área sob a curva (ASC) e as taxas de eficácia do florfenicol para os efeitos bacteriostático, bactericida e de erradicação bacteriológica. A dose de 20 mg/Kg IV demonstrou efeitos de erradicação de 100, 93 e 0% para CIM de 0,5, 1 e acima, respectivamente. O efeito bacteriostático foi de 99 e 90% para CIM de 4 e 2 µg/ml, enquanto o bactericida foi de 14% para CIM de 2 µg/ml. A dose de 30 mg/Kg IV apresentou 100% de erradicação para CIM de 1 µg/mL e 100% de efeito bactericida para CIM de 2 µg/mL. Há 100% de efeito bacteriostático em CIM de 4 µg/ml. As doses de 20 e 30 mg/Kg IM mostraram 100% de erradicação para CIM até 1 µg/mL e 0% para CIM maiores. O efeito bacteriostático foi mantido em 100% para uma CIM de 4 µg/mL em ambas as doses. Este estudo mostra o efeito de erradicação bacteriológica do florfenicol nas doses de 20 e 30 mg/Kg, IV e IM. Recomenda-se que seja feito um estudo de eficácia in vivo com a dose de 30mg/Kg IM em ovinos infectados por F. necrophorum com MIC superior a 2 µg/mL.

We aimed to compare the in silico effect of florfenicol at doses of 20 and 30 mg/Kg in sheep by intravenous (IV) and intramuscular (IM) routes, using PK/PD modeling. We performed a Monte Carlo simulation based on plasma concentration data from a previously published study. We calculated the area under the curve (AUC) and the efficacy rates of florfenicol to bacteriostatic, bactericidal, and bacteriological eradication effects. The dose of 20 mg/Kg IV demonstrated 100, 93, and 0% eradication effects for MICs of 0.5, 1, and above, respectively. The bacteriostatic effect was 99 and 90% for MIC of 4 and 2 µg/ml, while the bactericide was 14% for MIC of 2 µg/ml. The 30 mg/Kg IV dose showed 100% eradication for MIC of 1 µg/mL and 100% bactericidal effect for MIC of 2 µg/mL. There is a 100% of bacteriostatic effect at MIC of 4 µg/ml. Doses of 20 and 30 mg/Kg IM showed 100% eradication for MIC up to 1 µg/mL and 0% for MIC above. The bacteriostatic effect was maintained at 100% for a MIC of 4 µg/mL at both doses. This study shows the bacteriological eradication effect of florfenicol at doses of 20 and 30 mg/Kg, IV, and IM. Therefore, we recommend an in vivo efficacy study with a dose of 30mg/Kg IM in sheep infected with F. necrophorum with MIC greater than two µg/mL.

Efectividad de la antibioticoterapia sistémica precoz en pacientes con endoftalmitis postraumática / Effectiveness of the early systemic antibiotic therapy in patients with postraumatic endophthalmitis

Introducción: La endoftalmitis postraumática se define como una marcada inflamación de los fluidos y tejidos de las cavidades intraoculares, provocada por la invasión y replicación de microorganismos después de un traumatismo ocular a globo abierto, lo cual puede ocasionar la pérdida de la visión. Objetivo: Evaluar la efectividad de la terapia antibiótica sistémica precoz en pacientes con endoftalmitis postraumática. Métodos: Se efectuó un estudio cuasiexperimental de 72 pacientes con traumatismo ocular a globo abierto, ingresados en el Centro Oftalmológico del Hospital General Docente Dr. Juan Bruno Zayas Alfonso de Santiago de Cuba, desde enero del 2017 hasta mayo del 2019. Se realizó un muestreo aleatorio simple; los pacientes se distribuyeron en 2 grupos: uno de control con 28 integrantes, a los cuales se le administró el tratamiento farmacológico habitual y otro de estudio con 44, quienes además de lo anterior recibieron terapia antibiótica sistémica. Resultados: Predominaron los pacientes masculinos, con edades entre 45 y 54 años (29,5 %); 72,7 % no mostraron antecedentes personales de interés y el trauma ocular ocurrió con más frecuencia en un ambiente rural (77,8 %). La zona 1 fue la más afectada (65,3 %); en 39,3 % de los pacientes la evolución del trauma fue menor de 6 horas, pero en el grupo que no recibió la terapéutica sistémica precoz y presentó endoftalmitis (10,7 %) este tiempo fue mayor, la reparación ocurrió tardíamente. Conclusiones: La terapia antibiótica sistémica precoz fue efectiva en la mayoría de los pacientes que recibieron este tratamiento contra la endoftalmitis postraumática.

Introduction: Postraumatic endophthalmitis is defined as a marked inflammation of the fluids and tissues of the intraocular cavities, caused by the invasion and replication of microorganisms after an ocular traumatism on open globe, that can cause loss of the vision. Objective: To evaluate the effectiveness of the early systemic antibiotic therapy in patients with postraumatic endophthalmitis. Method: A quasi-experiment study of 72 patients with ocular traumatism on open globe was carried out, they were admitted in the Ophthalmologic Center of Dr. Juan Bruno Zayas Alfonso Teaching General Hospital in Santiago de Cuba, from January, 2017 to May, 2019. A simple random sampling was carried out; patients were distributed in 2 groups: one of control with 28 members, that received the habitual pharmacological treatment and a study group with 44 members who received systemic antibiotic therapy besides the above-mentioned. Results: Male patients prevailed, aged between 45 and 54 years (29.5 %); 72.7 % didn't show personal history of interest and the ocular trauma happened with more frequency in a rural atmosphere (77.8 %). The area 1 was the most affected (65.3 %); in 39.3 % of the patients the clínical course of trauma was less than 6 hours, but in the group that didn't receive the early systemic therapy and presented endophthalmitis (10,7 %) this time was higher, the repair happened belatedly. Conclusions: The early systemic antibiotic therapy was effective in most of the patients that received this treatment against the postraumatic endophthalmitis.

Infecciones del sitio quirúrgico en un hospital de enseñanza. Estudio observacional / Surgical site infections in a teaching hospital. Observacional study

Objetivo: determinar el número de pacientes que desarrollaron una infección postquirúrgica, posibles agentes etiológicos y complicaciones.Métodos : se realizó un estudio retrospectivo observacional que incluye a todos los supervivientes de las cirugías electivas y de emergencia de los servicios de Cirugía I, II y III del Hospital Universitario de Caracas durante el año 2019. Los datos fueron recopilados a través de la revisión de historias médicas. 48 historias cumplieron los criterios de inclusión, en estas se analizaron distintas variables como: días de hospitalización, síntomas, resultados de laboratorio, cultivos microbiológicos y tratamientos. A partir de estas se elaboraron tablas de frecuencia y análisis bivariado (Chi-cuadrado de Pearson) con el programa IBM SPSS Statistics 26.Resultados : la prevalencia de las infecciones postoperatorias fue de 4,69% CI 95% = (2,79-7,16%) en los servicios de Cirugía (I, II y III) del hospital durante el año 2019, la mayoría ocurrieron tras cirugías de emergencia (87,50%) tales como: apendicectomías (45,83%) y colecistectomías (10,41%). Solo al 22,91% de estos pacientes se les realizó cultivo microbiológico donde se encontró:E. coli (10,50%), Enterococcus sp. y Klebsiella pneumoniae (6,24%), Morganella morganii (2,1%) y Streptococcus pneumoniae (2,1%). Conclusión : las infecciones del sitio quirúrgico siguen siendo una de las principales causas de morbi-mortalidad y aumento de la estadía hospitalaria en los servicios de cirugía, son de diversa etiología bacteriana y están mayormente asociadas a cirugías abdominales, de emergencia(AU)

Objective: to determine the number of patients that developed a surgical site infection (SSI), possible etiologic agents and complications.Methods : an observational and retrospective study that includes every patient that underwent and survived a surgical procedure at the general surgery I, II and III services at the University Hospital of Caracas between January and December 2019. The study data were collected through the review of the medical records. 48 medical records that met the inclusion criteria and different variables were analyzed, including: days of hospitalization, symptoms, laboratory results, microbiological cultures and treatments. From those variables, frequency tables and bivariate analysis (Pearson's Chi-Square) were created with the IBM SPSS Statistics 26 program.Results : the SSI prevalence was 4,69% CI 95%= (2,79-7,16%) including the three surgery services (I, II and III) at the University Hospital of Caracas during 2019. Most of these occurred after emergency surgeries (87,50%) among which stand out: appendectomy (45,83%) and cholecystectomies (10,41%). Microbiological cultures were performed only in 22,91% of these patients and the following bacteria were isolated:E. coli (10,50%), Enterococcus sp. plus Klebsiella pneumoniae (6,24%), Morganella morganii (2,1%) and Streptococcus pneumoniae (2,1%). Conclusion : Surgical Site Infection (SSI) continues to be one of the main causes of morbimortality and increased hospital stay in surgical services in the hospital. These infections have a diverse bacterial etiology and are mostly associated with abdominal or emergency surgeries(AU)

Características microbiológicas de los pacientes con úlcera del pie diabético / Microbiologic characteristics of patients with diabetic foot ulceration

RESUMEN Introducción: Las infecciones de las úlceras del pie diabético son comunes, complejas, de alto costo y constituyen la principal causa de amputación no traumática de las extremidades inferiores. Objetivo: Identificar los microorganismos aislados para estimar tanto la sensibilidad a los antibióticos como la coincidencia entre el tratamiento empírico y los resultados microbiológicos en pacientes con úlceras del pie diabético. Métodos: Se realizó una investigación descriptiva-retrospectiva. La población de estudio estuvo constituida por 210 pacientes ingresados en el Hospital Universitario Clínico Quirúrgico "Comandante Faustino Pérez Hernández" de Matanzas entre junio de 2017 y junio de 2020. Las variables de salida fueron la frecuencia y el tipo de germen, la cantidad de gérmenes por úlcera, la sensibilidad para cada tipo de antibiótico, y el porcentaje de coincidencia entre el tratamiento empírico y el resultado microbiológico. Resultados: Se identificaron 259 gérmenes y se observaron 1,23 gérmenes por úlcera. El 62,5 por ciento de los gérmenes encontrados fueron Gram negativos, pero el germen más representado fue el Staphylococcus aureus. El 58,8 por ciento de los Staphylococcus aureus se mostraron resistentes a la meticillin. La vancomicina y el linezolid resultaron efectivos en el 100 por ciento de los Gram positivos. La amikacina fue el antibiótico más efectivo para los Gram negativos. Se observó coincidencia entre el tratamiento empírico y el resultado del antibiograma en el 27,6 por ciento de los pacientes. Conclusiones: Resulta necesario un apropiado diagnóstico microbiológico de las úlceras del pie diabético para identificar los gérmenes presentes en las lesiones y diseñar algoritmos de terapia antimicrobiana adecuados(AU)

ABSTRACT Introduction: Diabetic foot ulcer infections are common, complex, high cost and are the leading cause of non-traumatic lower extremity amputation. Objective: To identify the microorganisms isolated to estimate both the sensitivity to antibiotics and the coincidence between empirical treatment and microbiological results in patients with diabetic foot ulcers. Methods: A descriptive-retrospective investigation was performed. The study population consisted of 210 patients admitted to the University Hospital "Comandante Faustino Pérez Hernández" of Matanzas between June 2017 and June 2020. The output variables were the frequency and type of germ, the number of germs per ulcer, the sensitivity for each type of antibiotic, and the percentage of coincidence between the empirical treatment and the microbiological result. Results: A total of 259 germs were identified and 1.23 germs per ulcer were observed. The 62.5 percent of the germs found were Gram negative, but the most represented germ was Staphylococcus aureus. Of the Staphylococcus aureus, 58.8 percentwere resistant to methicillin. Vancomycin and linezolid were effective in 100 percent of Gram positives. Amikacin was the most effective antibiotic for Gram-negatives. Agreement between empirical treatment and antibiogram result was observed in 27.6 percent of patients. Conclusions: An appropriate microbiological diagnosis of diabetic foot ulcers is necessary to identify the germs present in the lesions and to design adequate antimicrobial therapy algorithms(AU)

Piomiositis, artritis séptica y osteomielitis aguda porStaphylococcus aureus meticilino resistente de la comunidad enpaciente pediátrico / Pyomyositis, septic arthritis and acute osteomyelitis due tocommunity methicillin-resistant Staphylococcus aureus in apediatric patient

Las infecciones osteoarticulares y musculoesqueléticas son patologías infecciosas relativamente infrecuentes en la infancia, afectando generalmente a varones y menores de 5 años. Países desarrollados reportan una incidencia anual de osteomielitis de 10 a 80/100.000 niños y de 4 casos/100.000 niños para artritis séptica. En países tropicales, la piomiositis tiene una incidencia de un caso por cada 2.000 habitantes. El Staphylococcus aureus es el principal agente causal. En la infancia la vía más común del legada del germen a la articulación es la hematógena. Hasta en un 30% de niños coexisten osteomielitis aguda y artritis séptica. Se presenta el caso de preescolar masculino de 3años, quien posterior a aplastamiento de miembro inferior izquierdo, presenta aumento de volumen, dolor y limitación para la marcha, asociándose 9 días después fiebre de 39.5°C,acudiendo al Hospital Universitario de Caracas. La anamnesis, evaluación clínica y estudios paraclínicos fueron sugestivos depiomiositis de muslo izquierdo, osteomielitis de fémur izquierdo y artritis séptica de rodilla izquierda. Se indica antibioticoterapiacon cobertura para Staphylococcus aureus (ciprofloxacina y clindamicina). Se realizó artrotomía evacuadora y limpieza quirúrgica de estructuras afectadas. El cultivo reportó Staphylococcus aureus sensible a ciprofloxacina, gentamicina, linezolid, rifampicina, trimetropin/sulfametoxazol; resistentea clindamicina, eritromicina, oxacilina, por lo que se omitióclindamicina y se indicó trimetropin/sulfametoxazol. Cumplió21 días de tratamiento intravenoso, observándose evolución satisfactoria por lo que se decidió egreso, dando continuidad con tratamiento vía oral por cuatro semanas y seguimiento interdisciplinario. El abordaje oportuno y adecuado de estas patologías disminuye el riesgo de desarrollar complicaciones(AU)

Osteoarticular and musculoskeletal infections are relatively rare infectious diseases in childhood, generally affecting men and children under 5 years of age. Developed countries report an annual incidence of osteomyelitis of 10 to 80 / 100,000 children and 4 cases / 100,000 children for septicarthritis. In tropical countries, pyomyositis has an incidence of one case for every 2,000 inhabitants. Staphylococcus aureusis the main causative agent. In childhood the most commonroute of arrival of the germ to the joint is hematogenous.Up to 30% of children coexist acute osteomyelitis and septic arthritis. We present the case of a 3-year-old male preschoolerwho, after crushing his left lower limb, presented an increasein volume, pain, and limited gait, and was associated witha fever of 39.5 ° C 9 days later, going to the University Hospital of Caracas. the anamnesis, clinical evaluation and paraclinical studies were suggestive of pyomyositis of the leftthigh, osteomyelitis of the left femur and septic arthritis of the left knee. Antibiotic therapy with coverage for Staphylococcus aureus (ciprofloxacin and clindamycin) is indicated. Evacuating arthrotomy and surgical cleaning of affected structures were performed. The culture reported Staphylococcus aureus sensitiveto ciprofloxacin, gentamicin, linezolid, rifampin, trimetropin /sulfamethoxazole; resistant to clindamycin, erythromycin,oxacillin, therefore clindamycin was omitted and trimetropin /sulfamethoxazole was indicated. He completed 21 days ofintravenous treatment, observing satisfactory evolution so hisdis charge was decided, continuing with oral treatment for four weeks and interdisciplinary follow-up. The timely and adequate approach to these pathologies reduces the risk of developing complications(AU)

Modelagem farmacocinética/farmacodinâmica do florfenicol para o tratamento da adenite equina por meio da simulação de Monte Carlo / Pharmacokinetic/pharmacodynamic modeling of florfenicol for the treatment of equine adenitis using Monte Carlo simulation

O objetivo deste trabalho foi avaliar a eficácia do florfenicol na dose usualmente empregada em equinos de 22 mg/kg pelas vias intravenosa, intramuscular e oral para o tratamento de adenite equina por Streptococcus equi. subsp. equi, usando a modelagem farmacocinética/farmacodinâmica (PK/PD – Pharmacokinetic/Pharmacodynamic) e a simulação de Monte Carlo. Foi realizada uma simulação de Monte Carlo a partir dos parâmetros PK, logo depois, efetuou-se a modelagem PK/PD para determinar as taxas de eficácia do antimicrobiano para o tratamento dessa infecção bacteriana, de acordo com o valor da concentração inibitória mínima (CIM), em um intervalo de CIM de 0,125 – 4 μg/mL. Pela via intravenosa, a probabilidade de erradicação bacteriana foi de 100% para CIM até 0,5 μg/mL e efeito bacteriostático com probabilidades de 99% e 80% para CIMs de 2 e 4 μg/mL, respectivamente. Já pelas vias intramuscular e oral a probabilidade de se atingir o índice de erradicação bacteriológica foi de 100% para CIM de até 0,5 μg/mL, contudo, atinge valores de 80% e 81%, respectivamente, para CIM de 1 μg/mL considerando o efeito bactericida (p<0,01). Portanto, através desse estudo é evidenciado a eficácia do florfenicol até a CIM de 0,5 μg/mL para as três vias de administração citadas, entretanto, para CIMs superiores a esse valor, é imprescindível o ajuste da dose farmacológica, evitando falhas na terapêutica e possível resistência microbiana.

The objective of this study was to evaluate the efficacy of florfenicol at the dose usually used in horses of 22 mg/kg by intravenous, intramuscular and oral routes for the treatment of equine adenitis caused by Streptococcus equi. subsp. equi, using Pharmacokinetic/Pharmacodynamic (PK/PD) modeling and Monte Carlo simulation. A Monte Carlo simulation was performed from the PK parameters, then PK/PD modeling was performed to determine the antimicrobial efficacy rates for the treatment of this bacterial infection, according to the minimum inhibitory concentration (MIC) value, in a MIC range of 0.125 - 4 μg/mL. Intravenously, the probability of bacterial eradication was 100% for MICs up to 0.5 μg/mL, and the bacteriostatic effect was 99% and 80% for MICs of 2 and 4 μg/mL, respectively. However, for the intramuscular and oral routes, the probability of reaching the bacteriologic eradication index was 100% for MICs of up to 0.5 μg/mL, however, it reaches values of 80% and 81%, respectively, for MICs of 1 μg/mL considering the bactericidal effect (p<0.01). Therefore, through this study the efficacy of florfenicol is evidenced up to the MIC of 0.5 μg/mL for the three routes of administration cited, however, for MICs higher than this value, it is essential to adjust the pharmacological dose, avoiding failures in therapy and possible microbial resistance.

Modelagem farmacocinética/farmacodinâmica do florfenicol para o tratamento da adenite equina por meio da simulação de Monte Carlo / Pharmacokinetic/pharmacodynamic modeling of florfenicol for the treatment of equine adenitis using Monte Carlo simulation

O objetivo deste trabalho foi avaliar a eficácia do florfenicol na dose usualmente empregada em equinos de 22 mg/kg pelas vias intravenosa, intramuscular e oral para o tratamento de adenite equina por Streptococcus equi. subsp. equi, usando a modelagem farmacocinética/farmacodinâmica (PK/PD ­ Pharmacokinetic/Pharmacodynamic) e a simulação de Monte Carlo. Foi realizada uma simulação de Monte Carlo a partir dos parâmetros PK, logo depois, efetuou-se a modelagem PK/PD para determinar as taxas de eficácia do antimicrobiano para o tratamento dessa infecção bacteriana, de acordo com o valor da concentração inibitória mínima (CIM), em um intervalo de CIM de 0,125 ­ 4 µg/mL. Pela via intravenosa, a probabilidade de erradicação bacteriana foi de 100% para CIM até 0,5 µg/mL e efeito bacteriostático com probabilidades de 99% e 80% para CIMs de 2 e 4 µg/mL, respectivamente. Já pelas vias intramuscular e oral a probabilidade de se atingir o índice de erradicação bacteriológica foi de 100% para CIM de até 0,5 µg/mL, contudo, atinge valores de 80% e 81%, respectivamente, para CIM de 1 µg/mL considerando o efeito bactericida (p<0,01). Portanto, através desse estudo é evidenciado a eficácia do florfenicol até a CIM de 0,5 µg/mL para as três vias de administração citadas, entretanto, para CIMs superiores a esse valor, é imprescindível o ajuste da dose farmacológica, evitando falhas na terapêutica e possível resistência microbiana.

The objective of this study was to evaluate the efficacy of florfenicol at the dose usually used in horses of 22 mg/kg by intravenous, intramuscular and oral routes for the treatment of equine adenitis caused by Streptococcus equi. subsp. equi, using Pharmacokinetic/Pharmacodynamic (PK/PD) modeling and Monte Carlo simulation. A Monte Carlo simulation was performed from the PK parameters, then PK/PD modeling was performed to determine the antimicrobial efficacy rates for the treatment of this bacterial infection, according to the minimum inhibitory concentration (MIC) value, in a MIC range of 0.125 - 4 µg/mL. Intravenously, the probability of bacterial eradication was 100% for MICs up to 0.5 µg/mL, and the bacteriostatic effect was 99% and 80% for MICs of 2 and 4 µg/mL, respectively. However, for the intramuscular and oral routes, the probability of reaching the bacteriologic eradication index was 100% for MICs of up to 0.5 µg/mL, however, it reaches values of 80% and 81%, respectively, for MICs of 1 µg/mL considering the bactericidal effect (p<0.01). Therefore, through this study the efficacy of florfenicol is evidenced up to the MIC of 0.5 µg/mL for the three routes of administration cited, however, for MICs higher than this value, it is essential to adjust the pharmacological dose, avoiding failures in therapy and possible microbial resistance.

Endocarditis infecciosa en hospital clínico Herminda Martín de Chillán: experiencia de los últimos cinco años / Infective endocarditis at Herminda Martin clinical hospital of Chillan: last five years experience

Introducción: la endocarditis infecciosa es una afección con elevada morbilidad y mortalidad, con una incidencia en Chile de 2-3 casos por 100.000 habitantes al año, con una edad de presentación en ascenso y una clínica diversa e inespecífica que requiere un manejo multidisciplinario para el manejo de estos pacientes. Materiales y métodos: estudio observacional descriptivo, se consideró el número total de fichas clínicas del hospital clínico Herminda Martín de Chillán durante los años 2015 al 2019, con diagnóstico confirmado de endocarditis infecciosa. Los datos se registraron en la hoja de recolección de datos elaborada, realizándose los análisis estadísticos pertinentes. Resultados:la muestra (n=17) que pudo ser analizada tenía una edad promedio de 53,5 años; 70,5% (DE 14,50) fueron hombres y el agente más común identificado fue Staphylococcus aureus sensible a meticilina. En promedio los pacientes recibieron 28,8 días de antibióticos y la válvula más afectada fue la aórtica. Conclusiones: la endocarditis infecciosa es una patología con una gran morbimortalidad, que presenta un cuadro clínico inespecífico capaz de simular cualquier enfermedad. Se requieren aún de más estudios que reflejen la realidad nacional.

Introduction: Infective endocarditis is a condition with high morbidity and mortality, with an incidence in Chile of 2-3 cases per 100,000 inhabitants per year, with increasing age of presentation and a diverse and nonspecific clinic that requires multidisciplinary management for treatment of these patients. Materials and methods: Descriptive observational study, the total number of clinical records of the Herminda Martín de Chillán clinical hospital during the years 2015 to 2019, with a confirmed diagnosis of infective endocarditis, was considered. The data were recorded in the data collection sheet prepared, performing the relevant statistical analyses. Results: The sample (n = 17) that could be analysed had an average age of 53.5 years (DS 14.50), 70.5% were men, and the most common agent identified was methicillin-sensitive Staphylococcus aureus. On average, patients received 28.8 days of antibiotics, and the most affected valve was the aortic valve. Conclusions: Infective endocarditis is a pathology with high morbidity and mortality, which presents a nonspecific clinical spectrum, capable of simulating any disease. Still, more studies are required that reflect the national reality

Manejo de Otitis Media Aguda en los Servicios de Pediatría y Otorrinolaringología y Cirugía de Cabeza y Cuello del Hospital de Clínicas / Treatment of Acute Otitis Media in the Pediatrics and Otorhinolaryngology, Head and Neck services in the Clinical Hospital

La otitis media aguda (OMA) es una patología muy común en pediatría y constituye la indicación más frecuente de prescripción de antibióticos en la infancia. Para el diagnóstico se tienen en cuenta hallazgos en la otoscopia, diversos signos clínicos y el tiempo de evolución de los síntomas principales. La decisión de iniciar antibioticoterapia debe determinarse según cada paciente. La espera vigilante como alternativa a la antibioticoterapia inmediata en casos seleccionados reduce el uso de antibióticos sin aumentar el riesgo de daño al paciente y ha demostrado ser una medida costo-efectiva. El fármaco de elección para el tratamiento empírico de la OMA es la amoxicilina, aunque según nuestros resultados es la amoxicilina-IBL la utilizada como primera línea en ambos servicios.

Acute otitis media (AOM) is a pathology commonly found in pediatrics, and the most frequent cause of antibiotics prescription in infants. For its diagnostics, several criteria are taken in consideration, such as otoscopy observations, diverse clinical signs, and the time of evolution of the main symptoms. The decision to initiate antibiotic therapy must be determined particularly for each patient. As an alternative to immediate antibiotic therapy, watchful waiting is preferred in certain cases to reduce the antibiotic use without elevating the patients' risk and has been proven to be a cost-effective approach. The preferred drug for empiric antibiotic therapy in AOM is amoxicillin, although we have observed that the first choice in both our services, pediatrics and otorhinolaryngology, is amoxicillin-IBL.

Use of sulfonamides for the treatment of bovine neonatal diarrhea: clinical and performance parameters / Utilização de sulfonamidas para o tratamento de diarreia neonatal bovina: parâmetros clínicos e zootécnicos

This study was developed to evaluate the clinical, hematological, and performance parameters of calves affected by diarrhea caused by the bacterial enteric pathogen Escherichia coli, treated with three different protocols containing sulfonamides. Fourteen Holstein calves were monitored from birth to 60 days of age, and divided into 3 groups. Group 1 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, administered orally (BM), dissolved in 160 ml of water every 24 h; Group 2 (n=4) received IM sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), and Group 3 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, which is made up of 16 g of phthalylsulfathiazole, associated with 2.28 g neomycin sulfate, 1.6 g of pectin, and 80 g of kaolin, dissolved in 160 ml of water and administered every 24 h by mouth, in addition to sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), at a daily dose of 16 mg/kg live weight, through IM injection. During the study, the animals were clinically evaluated, and once they were diagnosed with diarrhea, feces samples were collected to identify the bacterial enteric pathogen, antibiogram, polymerase chain reaction (PCR), and coproparasitological exams. Blood samples were collected to evaluate the hematological profile, and the performance profile was monitored weekly. In the clinical examination, all calves presented a reduction in body temperature (<39.2°C) and some improvement in hydration after treatment (p=0,31). However, group 2 had a better concentration of lymphocytes and TP concerning the other animals, as well as better performance. Besides, E.coli was detected in 100% of feces samples. Thus, the therapeutic protocols with sulfonamides used to treat bovine neonatal diarrhea were effective in the clinical improvement of the animals. Nonetheless, the protocol with systemic therapy using sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil) intramuscularly, provided better performance, with better weight gain, and body development of the animals.(AU)

Este estudo foi desenvolvido com o objetivo de avaliar parâmetros clínicos, hematológicos e zootécnicos de bezerras acometidas por diarreia provocada pelo agente bacteriano Escherichia coli, tratadas com três diferentes protocolos contendo sulfonamidas. Quatorze bezerras da raça Holandês foram monitoradas do nascimento até os 60 dias de vida e divididas em 3 grupos: Grupo 1 (n=5), animais tratados com a dose de 80g de Kaopek®, Ibasa, Brasil, por via oral (VO), dissolvido em 160ml de água a cada 24 horas; Grupo 2 (n=4) receberam sulfadiazina e trimetropim (Ibatrim®, Ibasa, Brasil), na dose de 16mg/Kg de peso vivo, por dia, por via intramuscular (IM); Grupo 3 (n=5) 80g de Kaopek®, Ibasa, Brasil, por VO dissolvido em 160ml de água, a cada 24 horas e com 16mg/Kg de peso vivo, por dia, de sulfadiazina e trimetoprim (Ibatrim®, Ibasa, Brasil), por via IM. Durante o estudo, os animais foram avaliados clinicamente e a partir do diagnóstico de diarreia foram coletadas amostras de fezes para a identificação do agente bacteriano, antibiograma, reação em cadeia da polimerase (PCR) e exames coproparasitológicos. Amostras de sangue foram coletadas para avaliação do perfil hematológico e o perfil zootécnico foi acompanhado semanalmente. No exame clínico, todas as bezerras apresentaram redução na temperatura corporal (<39,2°C) e melhora na hidratação após o período de tratamento (p=0,31), porém o grupo 2 obteve maior concentração de linfócitos e PPT em relação aos demais, assim como melhor desempenho zootécnico, além disso em 100% das amostras de fezes foi detectado E. coli. Sendo assim, os protocolos terapêuticos com sulfonamidas utilizados para o tratamento da diarreia neonatal bovina foram eficazes na melhora clínica dos animais. Porém, o protocolo com terapia sistêmica com sulfadiazina e trimetoprim (Ibatrim®, Ibasa, Brasil) por via intramuscular proporcionou um melhor desempenho zootécnico, com melhor ganho de peso e desenvolvimento corporal dos animais.(AU)

Bola de Bichat para tratamento de fístula buco-sinusal: relato de caso / Bichat ball for the treatment of buco-sinusal fistula: case report

Introdução: O seio maxilar possui íntima relação com os molares e, por esse motivo, após a extração desses elementos, pode ocorrer comunicação entre as cavidades bucais e sinusais. Quando o canal que possibilita a comunicação entre as cavidades é revestido por epitélio, chamamos de fístula buço-sinusal. O diagnóstico se dá por meio dos aspectos clínicos e radiográficos. O tratamento deve ser imediato, para que ocorra fechamento espontâneo. O objetivo deste trabalho é discutir um fechamento de Fístula Buco-Sinusal com tratamento expectante do seio maxilar e manejo cirúrgico associado à sinusite. Relato de caso: Homem, 33 anos, compareceu à FOP-UPE relatando incômodo ao ingerir alimentos e história de exodontia traumática do elemento 17 há 1 ano. Ao exame intra-oral, observou-se a presença da fístula na região da exodontia e, ao exame tomográfico, foi observada radiopacidade em seio maxilar, sugerindo fenestração óssea e sinusite, respectivamente. Iniciou-se antibioticoterapia e descongestionante nasal para sinusite e posterior cirurgia de fechamento da fístula buco-sinusal com uso da bola de Bichat. O manejo adequado é essencial no sucesso terapêutico da fístula. Além disso, a avaliação clínica e a radiográfica auxiliam na sua prevenção. Considerações Finais: Nosso caso concordou com a literatura, demonstrando que o uso da bola de Bichat é um método simples, conveniente e confiável para a reconstrução de defeitos intraorais de pequeno a médio porte... (AU)

Introduction: The maxillary sinus has a relation with the molars, for this reason, after extraction of these teeth can occur communication between buccal and sinus cavities. When the channel that allows the communication between the cavities is coated epithelium, we diagnose oroantral fistula. The diagnosis is made through clinical and radiographic aspects. Treatment should be immediate so that spontaneous closure occurs. The objective of this study is to discuss a closure of Buco-Sinus Fistula with expectant treatment of the maxillary sinus and surgical management associated with sinusitis. Case report: Man, 33 years old, attended FOP-UPE reporting discomfort when eating food and history of traumatic exodontia of element 17, 1 year ago. The intra-oral examination revealed the presence of the fistula in the region of the exodontia and at the tomographic examination radiopacity was observed in the maxillary sinus, suggesting bone fenestration and sinusitis, respectively. Antibiotic therapy and nasal decongestant for sinusitis and subsequent closure of the bucosinus fistula with Buccal Fat were started. Adequate management is essential for the therapeutic success of the fistula. In addition, clinical and radiographic evaluation helps to prevent. Final considerations: Our case corroborates the literature, showing that the use of the bichat ball is a simple, convenient and reliable method for the reconstruction of small to medium sized intraoral defects... (AU)

Medicamentos en pacientes con riesgo quirúrgico y su repercusión en Estomatología / Medicine use in surgery risk patients and repercussion in Dentistry

RESUMEN • Introducción: Con el envejecimiento creciente de la población, la práctica estomatológica exige la utilización del conocimiento para identificar y tratar pacientes con enfermedades sistémicas cada vez más frecuentes, lo cual puede requerir el uso de medicamentos capaces de interactuar con el tratamiento farmacológico de su enfermedad de base. La literatura refleja esta relación de manera fragmentada y carente de un enfoque sistémico. Objetivo: Identificar en la literatura el uso de medicamentos en pacientes con riesgo quirúrgico y describir su repercusión durante el tratamiento estomatológico. Material y Métodos: Se realizó una revisión bibliográfica y se consultaron artículos científicos, tesis de titulación de especialistas, maestrías y doctorales entre otras referencias principalmente de los últimos 5 años mediante Google. Desarrollo: Se abordan las generalidades, manejo estomatológico y las interacciones medicamentosas de cada una de las enfermedades a estudiar (Diabetes Mellitus, hipertensión arterial y cardiopatía), así como las situaciones que requieren profilaxis antibiótica. Conclusiones: Los pacientes con riesgo quirúrgico utilizan medicamentos que producen interacciones importantes con fármacos como AINES, anestésicos locales y glucocorticoides que habitualmente se emplean en los tratamientos estomatológicos; existen además enfermedades sistémicas en las cuales hay que tener en cuenta la profilaxis antibiótica antes de realizar determinados procederes estomatológicos.

ABSTRACT • Introduction: With the growing of population aging, the dental practice requires the adequate knowledge to identify and treat patients with increasingly frequent systemic diseases, which may require the use of drugs capable of interacting with the pharmacological treatment of their underlying diseases. The literature reflects this relationship in a fragmented manner and lacking a systemic approach. Objective: To identify the drugs used in risk patients undergoing surgery and describe their repercussion during dental treatment. Material and Method: A bibliographic review was carried out. Scientific articles, specialists´ theses, Master´s and PhD degrees among other references were consulted, mainly the ones obtained from the search carried out in Google during the last 5 years. Results: The generalities, dental management and drug interactions between the diseases studied (diabetes mellitus, arterial hypertension and heart disease) were addressed, as well as the situations that require antibiotic prophylaxis. Conclusions: The surgical risk patients studied use drugs that produce important interactions with drugs such as NSAIDs, local anesthetics and glucocorticoids that are usually used in dental treatments. There are also systemic diseases in which antibiotic prophylaxis must be taken into account before performing certain dental procedures.

Caracterización de la bacteremia por Staphylococcus aureus en pacientes hospitalizados del Hospital San Juan de Dios entre enero 2015 a diciembre 2017 / Characterization of bacteremia by Staphylococcus aureus in hospitalized patients of the San Juan de Dios Hospital between January 2015 to December 2017

Resumen Introducción: Staphylococcus aureus es un importante patógeno humano que causa una amplia gama de infecciones clínicas; es una de las principales causas de bacteremia, endocarditis infecciosa, así como de infecciones osteoarticulares, cutáneas, tejidos blandos e infecciones pleuro-pulmonares. La bacteriemia es quizás la manifestación mejor descrita de la infección por S. aureus. Varios estudios han documentado la prevalencia, el pronóstico y el resultado de la bacteriemia por S. aureus (SAB) en las regiones industrializadas del mundo. Sin embargo, muchas preguntas básicas sobre la epidemiología del SAB, en particular en las regiones no industrializadas del mundo, permanecen sin respuesta. Materiales y métodos: Se trata de un estudio observacional, descriptivo, de tipo retrospectivo realizado en el Hospital San Juan de Dios entre los años de 2015 al 2017. El objetivo del estudio es describir las características clínicas y de laboratorio en pacientes a los que se le documento una bacteremia por S. aureus en el periodo en cuestión. Resultados y Conclusiones: la mayoría de los pacientes son masculinos, con mayor incidencia en pacientes mayores de 60 años. La estancia hospitalaria promedio fue de 43 días. La bacteremia por S. aureus adquirida en el hospital fue la más frecuente. El 43,9% de los pacientes se presentan con sepsis severa o shock séptico al momento del diagnóstico. La infección de piel y tejidos blandos es la infección asociada más común. Se documento que los factores de riesgo más importantes para desarrollar una bacteremia por S. aureus es la cirugía y hospitalización previa. Las comorbilidades más frecuente asociadas son la diabetes mellitus, hipertensión arterial, enfermedad renal crónica. La invasión más frecuente fue el catéter venoso central. Solo el 78% de los pacientes con bacteremia por S. aureus recibió un tratamiento antibiótico adecuado Solo el 52.5% de todos los casos tuvo un manejo óptimo de la bacteremia.

Abstract Introduction: Staphylococcus aureus is an important human pathogen that causes a wide range of clinical infections; It is one of the main causes of bacteremia, endocarditis, infectious, as well as musculoskeletal, skin infections and soft, pleuro-pulmonary tissues. Bacteremia is perhaps best described by S. aureus infection manifestation. Several studies have documented the prevalence, prognosis and outcome of bacteremia by S. aureus (SAB) in the industrialized regions of the world. However, many basic questions about the epidemiology of the SAB, particularly in non-industrialized regions of the world, remain unanswered. Materials and methods: It's an observational, descriptive, study retrospective type made in the Hospital San Juan de Dios between the years from 2015 to 2017. The study objective is to describe, laboratory and clinical characteristics in patients who were documented a bacteremia by S. aureus in the period in question. Results and conclusions: the majority of patients are male, with higher incidence in patients older than 60 years. The average hospital stay was 43 days. Bacteraemia by S. aureus acquired in the hospital was the most frequent. 43.9% of patients present with severe sepsis or septic shock at the time of diagnosis. Skin and soft tissue infection is the most common associated infection. Document risk factors more important in developing a S. aureus bacteremia is prior hospitalization and surgery. Comorbidities most frequent associates are diabetes mellitus, hypertension, renal disease chronic. The invasion most frequent was the central venous catheter.

Neumonía necrotizante en paciente pediátrico / Necrotizing pneumonia in a pediatric patient

La neumonía es la causa de muerte de aproximadamente 4 millones de niños al año en todo el mundo, la gran mayoría en países en desarrollo. En el primer año de vida, la incidencia es de 15-20 casos/1.000 niños/año. De 1 a 5 años asciende a 30-40 casos y, de nuevo, desciende en los mayores de 5 años a 10-20 casos/1.000 niños/año. Es una infección aguda del tracto respiratorio inferior adquirida en la comunidad con una duración inferior o igual a 14 días, que produce tos y/o dificultad respiratoria y con evidencia radiológica de infiltrado pulmonar agudo. El Streptococcus pneumoniae es el principal agente bacteriano. Se presenta el caso de un preescolar masculino de 2 años de edad. Inicia su enfermedad actual con rinorrea hialina anterior, hipertermia no cuantificada, tos seca. Es evaluado por facultativo y realizan paraclínicos que reportan leucocitosis, neutrofília y trombocitosis reactiva, diagnostican infección respiratoria baja e indican tratamiento antimicrobiano vía oral, el cual cumple sin evidenciar mejoría. Posteriormente se asocia dificultad respiratoria, consulta a centro de salud donde ingresan e indican tratamiento médico durante 48 horas sin mejoría clínica, refieren al Hospital Universitario de Caracas en regulares condiciones generales. En TAC de tórax se evidencian imágenes sugestivas de neumonía necrotizante bilateral, se indica doble antibioticoterapia durante 11 días para dar cobertura a Streptococcus pneumoniae resistente y/o Staphylococcus Aureus meticilino resistente adquirido en la comunidad, productor de leucocidina Panton - Valentine. Con evolución clínica satisfactoria egresa, con antibioticoterapia vía oral por 21 días y control por Neumopediatría(AU)

Pneumonia is the cause of death of approximately 4 million children a year around the world, the vast majority in developing countries. In the first year of life, the incidence is 15-20 cases/1,000 children/year. From 1 to 5 years it reaches 30-40 cases and, again, it goes down in those older than 5 years to 10-20 cases/1,000 children/year. It is an acute infection of the lower respiratory tract acquired in the community with a duration of less than or equal to 14 days, which causes cough and / or respiratory distress and with radiological evidence of acute pulmonary infiltrate. Streptococcus pneumoniae is the main bacterial agent. The case of a 2-year-old male preschooler is presented. He begins his current illness with anterior hyaline rhinorrhea, hyperthermia not quantified, dry cough. It is evaluated by a physician and performs paraclinics that report leukocytosis, neutrophilia and reactive thrombocytosis, diagnose a lower respiratory infection and indicate antimicrobial treatment by oral route, which does not show improvement. Afterwards, respiratory distress is associated, consultation with the health center where they enter and indicate medical treatment during 48 hours without clinical improvement, refer to the University Hospital of Caracas in regular general conditions. Chest CT shows suggestive images of bilateral necrotizing pneumonia, double antibiotic therapy is indicated for 11 days to cover resistant Streptococcus pneumoniae and / or community-acquired methicillin-resistant Staphylococcus Aureus, producer of Panton - Valentine leukocidin. With satisfactory clinical evolution, he withdrew, with oral antibiotic therapy for 21 days and control by Pneumopediatrics(AU)

Mammary gland health of Santa Inês ewes at the drying and puerperium and evaluation of a dry-off terapy with gentamicin / Sanidade da glândula mamária de ovelhas Santa Inês na secagem e no puerpério e avaliação da terapia intramamária com gentamicina na secagem

Mastitis represents an important health problem for Santa Inês breed, causing losses to the producer, due to loss of ewes or the decrease in weight gain of lambs. The aim of this work was to assess the health of the mammary gland of Santa Inês ewes at the drying and puerperium and to investigate the efficacy of a dry-off therapy with gentamicin. In this study, 64 ewes were divided in a control group (GC) and treatment group (GT), and the health of the mammary gland was assessed at the drying and puerperium. The GT ewes received 250mg of gentamicin (Gentocin® DryCow/Schering-Plough, product indicated for use in dairy cows) in each mammary half. For diagnosis, clinical examination, California Mastitis Test, somatic cell count and milk culture was performed. In the GC, of the 45 (70.3%) healthy mammary halves at the drying, 12 developed subclinical mastitis and nine clinical mastitis at the puerperium. In the GT, among 51 (79.7%) healthy mammary halves at the drying, six developed subclinical mastitis and 11 clinical mastitis at the puerperium. No association was observed between treatment and the occurrence of mastitis at puerperium. Of the 19 (29.7%) mammary halves of the GC that presented subclinical mastitis at the drying, three remained with subclinical mastitis and five developed clinical mastitis at the puerperium. In the GT, of the 13 (20.3%) mammary halves that had subclinical mastitis at the drying, four remained with subclinical mastitis and four developed clinical mastitis. No association was observed between treatment and cure or persistence of mastitis at the puerperium. The main microorganisms isolated, at the drying and puerperium, from animals with subclinical or clinical mastitis were Staphylococcus spp., predominantly coagulase negative Staphylococcus (CSN). At the puerperium, 29 cases of clinical mastitis occurred, 19 with isolation, where 10 were CNS and six S. aureus. Mannheimia haemolytica was isolated in one case of subclinical mastitis and other of clinical mastitis. News protocols and different ways of handling at drying and at puerperium must be investigated.(AU)

A mastite é um problema sanitário importante em ovelhas da raça Santa Inês, ocasionando prejuízo ao produtor em virtude do descarte de matrizes e da queda no ganho de peso dos cordeiros. O objetivo deste trabalho foi avaliar a saúde da glândula mamária de ovelhas da raça Santa Inês na secagem e no puerpério e pesquisar a eficácia da terapia intramamária com gentamicina na secagem. Sessenta e quatro ovelhas foram divididas em grupos controle (GC) e tratamento (GT), cada um contendo 32 animais, e a saúde da glândula mamária avaliada na secagem e no puerpério. As ovelhas do GT receberam 250mg de gentamicina (Gentocin® Mastite Vaca Seca/ Schering-Plough Veterinária, produto indicado pela empresa para utilização em vacas de leite) em cada metade mamária. Para o diagnóstico, foram realizados exame físico da glândula mamária, California Mastitis Test, contagem de células somáticas e cultura do leite. No GC, das 45 (70,3%) metades mamárias sadias na secagem, 12 desenvolveram mastite subclínica e nove mastite clínica no puerpério. No GT, das 51 (79,7%) metades mamárias sadias na secagem, seis desenvolveram mastite subclínica e 11 mastite clínica no puerpério. Não houve associação entre o tratamento e a ocorrência de mastite no puerpério. Das 19 (29,7%) metades mamárias do GC que apresentaram mastite subclínica na secagem, três permaneceram com mastite subclínica e cinco desenvolveram mastite clínica no puerpério. No GT, das 13 (20,3%) metades mamárias com mastite subclínica na secagem, quatro permaneceram com mastite subclínica e quatro desenvolveram mastite clínica. Não houve associação entre o tratamento e a cura ou persistência da mastite no puerpério. Os principais micro-organismos isolados, na secagem e puerpério, de animais com mastite subclínica ou clínica foram Staphylococcus spp., com predominância de Staphylococcus Coagulase Negativa (SCN). No puerpério, ocorreram 29 casos de mastite clínica, sendo 19 com isolamento, 10 com SCN e seis com S. aureus. Mannheimia haemolytica foi isolado em um caso de mastite subclínica e um caso de mastite clínica. Novos protocolos e diferentes formas de manejo na secagem e no puerpério devem ser pesquisados.(AU)

Garré`s osteomyelitis: a case report with a 6-month follow-up

Introduction: Garrè's osteomyelitis is a rare, chronic infection associated with proliferative periostitis that induces reactional bone neoformation. Objective: To report the clinical case of successful treatment of Garre's osteomyelitis in a young patient. Case report: An 11-year-old girl visited a dental clinic with complaints of volume increase in the mandibular border accompanied by pain and facial asymmetry. Computed tomography revealed extensive tooth destruction, a periapical lesion, and several radiopaque bone laminations parallel to the mandible cortex, all findings suggestive of Garrè's osteomyelitis. The patient was treated by tooth removal and antibiotic therapy, and the condition was completely resolved, with decreased facial asymmetry at the 6-month follow up. Conclusion: Once the diagnosis of Garrè's osteomyelitis is established and proper treatment is provided, the prognosis tends to be extremely favorable and bone remodeling should be considered until the affected surface returns to its normal anatomy.

Introdução: A osteomielite de Garrè é um tipo raro e crônico de infecção óssea associado a periostite proliferativa que induz neoformação óssea reacional. Objetivo: relatar o caso clínico de osteomielite de Garrè em uma paciente jovem tratada com sucesso. Relato de caso : Paciente do gênero feminino, 11 anos compareceu ao serviço odontológico com queixa de aumento de volume em borda de mandíbula acompanhada de dor e assimetria facial. A tomografia computadorizada revelou extensa destruição dentária associada a lesão periapical e a presença de várias laminações ósseas radiopacas paralelas ao cortical da mandibula, sugerindo o diagnóstico de osteomielite de Garrè. O caso foi tratado com a remoção do elemento dentário associado a antibioticoterapia, o que resolveu completamente a infecção e diminuiu a assimetria facial conforme constatado após 6 meses de proservação. Conclusão: Uma vez estabelecido o diagnóstico de osteomielite de Garrè, e a infecção adequadamente tratada, o prognóstico tende a ser extremamente favorável e a remodelação óssea deve ocorrer continuamente até que a superfície retorne à sua anatomia normal.

Estudio de pacientes ingresados por peritonitis en el Centro Nacional de Cirugía de Mínimo Acceso / Study of patients with peritonitis admitted to the National Center for Minimal Access Surgery

Introducción: La peritonitis postoperatoria es una de las complicaciones más frecuentes que se presenta tras procederes laparoscópicos. Objetivo: Caracterizar la evolución de los pacientes complicados con peritonitis después de un proceder laparoscópico. Material y método: Se realizó un estudio observacional descriptivo de los pacientes con peritonitis ingresados en la terapia intensiva, del Centro Nacional de Cirugía de Mínimo Acceso, desde septiembre de 2010 hasta diciembre de 2015. Se analizaron algunas variables demográficas, procederes laparoscópicos que se complicaron con este diagnóstico, complicaciones clínicas, antibioticoterapia utilizada, tipo de nutrición y la escala de evaluación fisiológica APACHE II como predictor de pronóstico. La información se obtuvo de las historias clínicas. Las variables cualitativas se resumieron utilizando frecuencias absolutas y porcentajes. Para las cuantitativas se utilizó la media y la desviación estándar. Resultados: Se complicaron con peritonitis 26 de 298 pacientes ingresados en el período (8,7 ), la edad media fue de 60 años, predominó el sexo femenino (57,7 por ciento). Se complicaron más con este diagnóstico los pacientes perforados postcolonoscopia (50 por ciento). El disbalance hidroelectrolítico (73,1 por ciento) fue la complicación asociada más frecuente. Se usó precozmente la nutrición enteral en 57,7 por ciento y los antibióticos más utilizados fueron ceftriaxone, amikacina y metronidazol. Predominó la evolución favorable a pesar que el score APACHE II se mantuvo en valores elevados. Conclusiones: Las perforaciones intestinales después de una colonoscopía tienen un alto riesgo de sufrir peritonitis secundaria, pero si se realiza un diagnóstico y tratamiento precoz su evolución es favorable(AU)

Introduction: Endoscopic dilatation is the first therapeutic option to eliminate benign esophageal stenosis and improve the symptoms and the quality of life of those patients who suffer from it. Objective:To describe the results of endoscopic dilatation in patients with benign esophageal stenosis treated in the National Center for Endoscopic Surgery from January 2015 to December 2016. Material and Methods:A case series longitudinal observational study was conducted in 59 patients with benign esophageal stenosis. Dilatations were done with Savary-Gilliard bougie and balloons. Results:The mean age was 52,5 years, and the condition predominated in 37 male patients (62,7 percent). Post-surgical, peptic, and caustic were the most frequent etiologies with 25, 14, and 6 cases, respectively. Short stenosis predominated in 51 cases. Bougies were used in 48 patients for a total of 149 dilatations, corresponding to a mean of 3,1 dilatations/ patients. Correction of the stenosis was made in 1-3 sessions in 47 percent of patients; 11 cases were dilated with balloon, corresponding to a mean of 1- 3 dilatations/ patients. Four patients from the group that were dilated with Savary-Gilliard bougies showed refractoriness. A perforation, and two bleedings occurred. After the dilatations, dysphagia improved or disappeared in 93,2 percent of patients. Conclusions:Endoscopic therapy through dilatation of benign esophageal stenosis indicated to be a good alternative method in achieving corrections in a few dilatation sessions, with a low number of complications, and an improvement of the dysphagia(AU)

Profilaxis quirúrgica y antibioticoterapia inicial / Surgical prophylaxis and initial antibiotic therapy

La infección de la herida quirúrgica es el resultado de una compleja interacción entre las bacterias inoculadas dentro de la herida durante la cirugía y la resistencia local y sistémica del huésped a la infección. El principal beneficio del antibiótico preoperatorio es la reducción del inóculo viable en la herida durante la incisión quirúrgica. Por otro lado, la antibioticoterapia empírica es definida como el tratamiento antibiótico basado en consideraciones clínicas, el conocimiento de los patógenos más frecuentemente involucrados y los patrones de susceptibilidad local. En este artículo haremos una revisión práctica de conceptos fundamentales en el uso racional de antibióticos en cirugía(AU)

Surgical wound infection is the result of a complex interaction between bacteria inoculated within the wound during surgery and the host's local and systemic resistance to infection. The main benefit of preoperative antibiotic is the reduction of the viable inoculum in the wound during surgical incision. On the other hand, empirical antibiotic therapy is defined as antibiotic treatment based on clinical considerations, knowledge of the most frequently involved pathogens and local susceptibility patterns. In this article we will make a practical review of fundamental concepts in the rational use of antibiotics in surgery(AU)

Antibioticoterapia como coadjuvante no tratamento periodontal não cirúrgico de pacientes diabéticos / Antibiotic therapy as an adjunct to non-surgical periodontal treatment in diabetic patients ­ a literature review

Objetivo: verificar se o uso de antibióticos sistêmicos, adjunto à terapia periodontal não cirúrgica, em pacientes diabéticos pode trazer benefícios adicionais no controle glicêmico e parâmetros clínicos periodontais. Material e métodos: após a busca nos bancos de dados PubMed e Lilacs, foram incluídos nove ensaios clínicos randomizados para essa revisão da literatura. Resultados: nos desfechos periodontais, seis dos nove ensaios clínicos encontraram algum benefício a favor da antibioticoterapia. Quanto ao controle glicêmico, a maioria dos estudos falhou ao tentar relacionar o uso de antibióticos a uma maior redução da hemoglobina glicada. Conclusão: com base nesta revisão, concluiu-se que o uso de antibióticos sistêmicos em conjunto com o tratamento periodontal não cirúrgico pode oferecer benefícios adicionais, quando comparado ao tratamento periodontal sozinho, no tratamento da periodontite em pacientes com diabetes. Não há evidências de que a antibioticoterapia possa contribuir no controle glicêmico desses pacientes, sendo necessários mais estudos clínicos.

Objective: to verify whether systemic antibiotic therapy along with non-surgical periodontal management in diabetic patients can bring additional benefi ts on the glycemic control and periodontal parameters. Material and methods: after an electronic search on Medline and Lilacs databases, 9 RCTs were included. Results: six articles found favorable outcomes for periodontal clinical parameters. Regarding the glycemic control, most studies failed to prove a relationship between antibiotic use and the reduction on glycated hemoglobin levels. Conclusion: within the limits of this review, it can be concluded that systemic antibioticotherapy added to non-surgical periodontal treatment can bring additional benefits when compared to non-surgical treatment alone for diabetes-affected periodontal patients. However, there is no evidence that antibiotics can contribute to the glycemic control and more studies are necessary on this subject.